Source: Annual Congress 2007 - Pulmonary vascular involvement in smoking and respiratory diseases
Disease area: Airway diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. S. von Ungern-Sternberg, A. Regli, F. Petak, M. Beghetti, W. Habre (Geneva, Switzerland; Szeged, Hungary). Precapillary pulmonary hypertension induced by aorto-caval shunt leads to a reversible bronchial hyperreactivity in rats. Eur Respir J 2007; 30: Suppl. 51, 3580

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary vein banding-induced pulmonary venous congestion causes pulmonary hypertension in rats. Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension Year: 2021 SuHx rat model: partly reversible pulmonary hypertension and progressive intima obstruction Source: Eur Respir J 2014; 44: 160-168 Year: 2014 MnTBAP reduces pulmonary vascular remodeling in experimental pulmonary arterial hypertension Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench Year: 2019 Increase of oxidative stress and pulmonary arterial inflammatory remodeling under high-flow conditions in experimental pulmonary hypertension Source: Annual Congress 2007 - Pulmonary circulation Year: 2007 Pulmonary hypertension correlates with increase in pulmonary interstitial pressure and decreased capillary patency Source: Annual Congress 2009 - Pulmonary circulation Year: 2009 Pulmonary hypertension in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 21: 892-905 Year: 2003 Pulmonary hypertension in mitral stenosis is associated with pulmonary venules fibrosis Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects Year: 2010 Improvement of exercise capacity in monocrotaline induced pulmonary hypertension by the phosphodiesterase inhibitor Vardenafil Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals Year: 2006 Frequency of exercise induced pulmonary hypertension after pulmonary embolism Source: Eur Respir J 2006; 28: Suppl. 50, 401s Year: 2006 Endothelin-1 and pulmonary artery pressures in acute pulmonary exacerbation of cystic fibrosis Source: Eur Respir J 2001; 18: Suppl. 33, 416s Year: 2001 Response to hypoxia of pulmonary arteries in chronic obstructive pulmonary disease: an in vitro study Source: Eur Respir J 2002; 20: 332-338 Year: 2002 Pulmonary artery distensibility correlates with functional response to sildenafil in distal chronic thrombo-embolic pulmonary hypertension Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases Year: 2008 Right-to-left shunt in pulmonary hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 344s Year: 2007 Pulmonary hypertension and endothelial dysfunction in patients with bronchial asthma Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008 Bosentan fails to prevent the development of pulmonary arterial hypertension in athymic rats exposed to chronic hypoxia Source: Annual Congress 2010 - Pulmonary vascular diseases Year: 2010 Effect of normobaric hypoxia on pulmonary hemodynamics in patients with precapillary pulmonary hypertension Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension Year: 2017 TRAM-34 ameliorates hypoxia-induced pulmonary arterial hypertension in rats Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments Year: 2013 Pulmonary arterial hypertension in combined pulmonary emphysema and fibrosis Source: Annual Congress 2005 - Pulmonary arterial hypertension diagnosis and therapy Year: 2005 Caspase inhibition reduces severe pulmonary hypertension in the AdTGF-1β/SU5416 model of angioproliferative pulmonary hypertension and lung fibrosis Source: Annual Congress 2011 - Experimental pulmonary hypertension Year: 2011 Biphasic cuirass ventilation decreased the indices of pulmonary circulation in patients with secondary pulmonary hypertension Source: Annual Congress 2011 - Treatment of human pulmonary hypertension Year: 2011